GT Healthcare Capital Partners, also known as GT Capital, is a venture capital firm based in Hong Kong with a second office in Shanghai, founded in 2015. It invests across medical devices and new drug development, backing biotech and medtech companies that combine scientific breakthroughs with clinical and commercial application, largely in the US and UK.
The portfolio includes Oxford Nanopore (p...
New York, United States
London, United Kingdom
Ann Arbor, Michigan, United States
San Francisco, United States
Pasadena, United States
Palo Alto, United States